Ginsenoside Rg3 promotes cytotoxicity of Paclitaxel through inhibiting NF-κB signaling and regulating Bax/Bcl-2 expression on triple-negative breast cancer
Author:
Publisher
Elsevier BV
Subject
Pharmacology,General Medicine
Reference43 articles.
1. Cancer statistics;Siegel;CA. Cancer J. Clin.,2017
2. Triple-negative breast cancer in African-American women: disparities versus biology;Dietze;Nat. Rev. Cancer,2015
3. Outcome disparities in African American women with triple negative breast cancer: a comparison of epidemiological and molecular factors between African American and Caucasian women with triple negative breast cancer;Sturtz;BMC Cancer,2014
4. Prognostic impact of 18F-FDG PET/CT staging and of pathological response to neoadjuvant chemotherapy in triple-negative breast cancer;Groheux;Eur. J. Nucl. Med. Mol. Imaging,2015
5. Nab-paclitaxel for the treatment of triple-negative breast cancer: rationale, clinical data and future perspectives;Schettini;Cancer Treat. Rev.,2016
Cited by 100 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Targeting Peroxisome Proliferator-Activated Receptor-β/δ, Reactive Oxygen Species and Redox Signaling with Phytocompounds for Cancer Therapy;Antioxidants & Redox Signaling;2024-02-01
2. Ginsenoside 20(S)-Rg3 reduces KIF20A expression and promotes CDC25A proteasomal degradation in epithelial ovarian cancer;Journal of Ginseng Research;2024-01
3. New insights into the correlations between circulating tumor cells and target organ metastasis;Signal Transduction and Targeted Therapy;2023-12-21
4. Ginsenoside Rg3 endows liposomes with prolonged blood circulation and reduced accelerated blood clearance;Journal of Controlled Release;2023-12
5. Fundamental Considerations of Targeted Drug Therapies for Breast Cancer;Future Pharmacology;2023-10-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3